H
Hossein Baharvand
Researcher at University of Science and Culture
Publications - 487
Citations - 20462
Hossein Baharvand is an academic researcher from University of Science and Culture. The author has contributed to research in topics: Embryonic stem cell & Stem cell. The author has an hindex of 56, co-authored 454 publications receiving 15081 citations. Previous affiliations of Hossein Baharvand include Avicenna Research Institute & Royan Institute.
Papers
More filters
Journal ArticleDOI
Increased robustness of early embryogenesis through collective decision-making by key transcription factors
Ali Sharifi-Zarchi,Ali Sharifi-Zarchi,Ali Sharifi-Zarchi,Mehdi Totonchi,Keynoush Khaloughi,Razieh Karamzadeh,Razieh Karamzadeh,Marcos J. Araúzo-Bravo,Marcos J. Araúzo-Bravo,Hossein Baharvand,Ruzbeh Tusserkani,Hamid Pezeshk,Hamidreza Chitsaz,Mehdi Sadeghi +13 more
TL;DR: It is proposed that a modular hierarchy of regulatory circuits, each consisting of two mutually inhibiting and auto-activating TF clusters, can form hierarchical lineage bifurcations with improved safeguarding of critical early embryogenesis against biological perturbations.
Journal ArticleDOI
Nuclear Proteome Analysis of Monkey Embryonic Stem Cells During Differentiation
Davood Nasrabadi,Mehran Rezaei Larijani,Ali Fathi,Hamid Gourabi,Ahmad Vosough Dizaj,Hossein Baharvand,Hossein Baharvand,Ghasem Hosseini Salekdeh +7 more
TL;DR: Functional interaction analysis of differentially expressed proteins revealed that most of nuclear proteins had a direct interaction with c-Myc and p53.
Journal ArticleDOI
Autologous bone marrow-derived CD133 cells with core decompression as a novel treatment method for femoral head osteonecrosis: a pilot study.
Mohsen Emadedin,Shahedeh Karimi,Aliasghar Karimi,Narges Labibzadeh,Maryam Niknejadi,Hossein Baharvand,Nasser Aghdami +6 more
TL;DR: This prospective quasi-experimental study demonstrated that, in patients with AVN, a single bone marrow-derived CD133+ cell injection into the necrotic site of the femoral head during CD is safe and effective in providing significant, clinically relevant pain relief and patients could do more activity over 2, 6 and 12 months.
Journal ArticleDOI
Long-Term Follow-up of Autologous Fibroblast Transplantation for Facial Contour Deformities, A Non-Randomized Phase IIa Clinical Trial.
Amir Bajouri,Zahra Orouji,Ehsan Taghiabadi,Abdoreza Nazari,Atefeh Shahbazi,Nasrin Fallah,Parvaneh Mohammadi,Rezvani M,Jouyandeh Z,Vaezirad F,Khalajasadi Z,Mahshid Ghasemi,Aslan Aghahossein Fanni,Haji Hosseinali S,Ahad Alizadeh,Hossein Baharvand,Saeed Shafieyan,Nasser Aghdami +17 more
TL;DR: Results have shown that autologous fibroblast transplantation could be a promising remodeling modality with long-term corrective ability and minimal adverse events (Registration Number: NCT01115634).
Journal ArticleDOI
The quest of cell surface markers for stem cell therapy
Anna Meyfour,Anna Meyfour,Sara Pahlavan,Mehdi Mirzaei,Jeroen Krijgsveld,Hossein Baharvand,Hossein Baharvand,Ghasem Hosseini Salekdeh,Ghasem Hosseini Salekdeh +8 more
TL;DR: The methodologies that have played a role in the discovery of cell surface markers are reviewed and single cell proteomics as an advanced tool is introduced, with emphasis on the nervous system, heart, pancreas, and liver.